Huadong Medicine Co., Ltd

XSEC:000963 Stock Report

Market Cap: CN¥62.1b

Huadong Medicine Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Liang Lv

Chief executive officer

CN¥2.4m

Total compensation

CEO salary percentagen/a
CEO tenure14.7yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure4yrs

Recent management updates

Recent updates

CEO

Liang Lv (50 yo)

14.7yrs

Tenure

CN¥2,400,000

Compensation

Mr. Liang Lv has been Chairman of the Board at Huadong Medicine Co., Ltd since June 06, 2019 and serves as its General Manager. He served as Deputy General Manager of Huadong Medicine Co., Ltd since April...

Board Members

NamePositionTenureCompensationOwnership
Liang Lv
Chairman & GM14.7yrsCN¥2.40mno data
Xinhua Bai
Chairman of Supervisory Committee26.9yrsno datano data
Jian Huang
Independent Director1.6yrsCN¥65.20kno data
Yun Qin
Supervisor18.6yrsno datano data
Wei Kang
Non-Independent Director8yrsCN¥30.00kno data
Liang Zhu
Non-Independent Director5.5yrsCN¥650.00kno data
Zhifeng Xu
Employee Supervisor5.5yrsno datano data
Feipeng Zhu
Non-Independent Director2.5yrsCN¥30.00kno data
Bo Ye
Non-Independent Director2.5yrsCN¥30.00kno data
Xiangdong Gao
Independent Director2.5yrsCN¥100.00kno data
Ruwei Wang
Independent Director2.5yrsCN¥100.00kno data
Yang Wang
Director1.4yrsCN¥13.60kno data

4.0yrs

Average Tenure

55yo

Average Age

Experienced Board: 000963's board of directors are considered experienced (4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 20:00
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Huadong Medicine Co., Ltd is covered by 38 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Changming HeBOCI Research Ltd.
Ethan CuiBofA Global Research
Shuchang LiuChangjiang Securities Co. LTD.